CA Stock MarketDetailed Quotes

ONC Oncolytics Biotech Inc

Watchlist
  • 1.440
  • +0.040+2.86%
15min DelayMarket Closed Jul 12 16:00 ET
108.60MMarket Cap-3600P/E (TTM)

Oncolytics Biotech Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-0.23%29.6M
8.63%34.91M
8.63%34.91M
23.54%39.98M
-27.72%24.35M
-24.85%29.67M
-22.11%32.14M
-22.11%32.14M
-32.70%32.36M
-33.68%33.69M
-Cash and cash equivalents
86.51%29.6M
199.26%34.91M
199.26%34.91M
23.54%39.98M
-48.00%17.52M
-59.80%15.87M
-71.73%11.67M
-71.73%11.67M
-32.70%32.36M
-33.68%33.69M
Total current assets
-2.57%33.38M
6.98%38.17M
6.98%38.17M
18.67%45.34M
-21.35%31M
-21.30%34.26M
-20.53%35.68M
-20.53%35.68M
-25.95%38.21M
-28.92%39.41M
Non current assets
-Accumulated depreciation
----
-13.19%-695K
-13.19%-695K
----
----
----
-17.85%-614K
-17.85%-614K
----
----
-Long term equity investment
150.79%948K
84.71%290K
84.71%290K
94.67%323K
80.12%346K
36.64%378K
-56.51%157K
-56.51%157K
-62.46%165.92K
-62.36%192.09K
-Including:Held to maturity investments
--623K
----
----
----
----
----
----
----
----
----
Regulatory assets
-86.03%102K
-97.12%15K
-97.12%15K
26.80%630K
57.20%559K
614.17%730K
-39.84%521K
-39.84%521K
97.70%496.86K
161.75%355.61K
Liabilities
Current liabilities
Current debt and capital lease obligation
-5.29%179K
-38.43%133K
-38.43%133K
-35.22%191K
-59.74%133K
-38.53%189K
-26.53%216K
-26.53%216K
9.71%294.86K
41.09%330.35K
-Current capital lease obligation
-5.29%179K
-38.43%133K
-38.43%133K
-35.22%191K
-59.74%133K
-38.53%189K
-26.53%216K
-26.53%216K
9.71%294.86K
41.09%330.35K
-accounts payable
----
-51.95%1.08M
-51.95%1.08M
--2.19M
--629K
----
279.12%2.25M
279.12%2.25M
----
----
-Total tax payable
8.02%7.68M
1.93%7.02M
1.93%7.02M
2.27%7.05M
2.22%7.08M
1.44%7.11M
-2.88%6.89M
-2.88%6.89M
-3.85%6.9M
-4.40%6.92M
Current accrued expenses
----
78.11%2.49M
78.11%2.49M
--2.35M
--1.74M
----
0.29%1.4M
0.29%1.4M
----
----
Current liabilities
66.18%4.1M
7.40%4.24M
7.40%4.24M
173.26%10.02M
4.20%2.65M
1.85%2.47M
46.65%3.95M
46.65%3.95M
35.33%3.67M
-1.47%2.54M
Non current liabilities
-Long term debt
150.79%948K
84.71%290K
84.71%290K
94.67%323K
80.12%346K
36.64%378K
-56.51%157K
-56.51%157K
-62.46%165.92K
-62.36%192.09K
Non current accrued expenses
62.86%1.37M
-0.77%647K
-0.77%647K
-0.23%752K
-10.56%744K
-7.76%840K
-33.20%652K
-33.20%652K
-24.64%753.71K
-4.42%831.87K
Total non current liabilities
23.01%11.78M
3.92%11.26M
3.92%11.26M
61.62%17.07M
2.75%9.73M
1.55%9.58M
10.75%10.83M
10.75%10.83M
6.89%10.56M
-3.63%9.47M
Shareholders'equity
Share capital
5.64%432.51M
6.65%430.91M
6.65%430.91M
7.73%428.83M
4.19%413.42M
3.26%409.41M
3.24%404.04M
3.24%404.04M
1.76%398.07M
1.45%396.81M
-common stock
5.64%432.51M
6.65%430.91M
6.65%430.91M
7.73%428.83M
4.19%413.42M
3.26%409.41M
3.24%404.04M
3.24%404.04M
1.76%398.07M
1.45%396.81M
Additional paid-in capital
5.75%42.69M
5.16%42.12M
5.16%42.12M
5.82%41.59M
4.09%40.39M
16.18%40.37M
17.24%40.05M
17.24%40.05M
18.43%39.3M
20.41%38.8M
Gains losses not affecting retained earnings
1.67%670K
-17.82%544K
-17.82%544K
-9.36%655K
22.23%554K
93.41%659K
70.62%662K
70.62%662K
77.79%722.63K
45.48%453.24K
Total equity
-1.64%34.75M
3.98%38.82M
3.98%38.82M
18.30%46.09M
-20.56%31.97M
-20.52%35.33M
-18.63%37.33M
-18.63%37.33M
-25.92%38.96M
-28.54%40.24M
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -0.23%29.6M8.63%34.91M8.63%34.91M23.54%39.98M-27.72%24.35M-24.85%29.67M-22.11%32.14M-22.11%32.14M-32.70%32.36M-33.68%33.69M
-Cash and cash equivalents 86.51%29.6M199.26%34.91M199.26%34.91M23.54%39.98M-48.00%17.52M-59.80%15.87M-71.73%11.67M-71.73%11.67M-32.70%32.36M-33.68%33.69M
Total current assets -2.57%33.38M6.98%38.17M6.98%38.17M18.67%45.34M-21.35%31M-21.30%34.26M-20.53%35.68M-20.53%35.68M-25.95%38.21M-28.92%39.41M
Non current assets
-Accumulated depreciation -----13.19%-695K-13.19%-695K-------------17.85%-614K-17.85%-614K--------
-Long term equity investment 150.79%948K84.71%290K84.71%290K94.67%323K80.12%346K36.64%378K-56.51%157K-56.51%157K-62.46%165.92K-62.36%192.09K
-Including:Held to maturity investments --623K------------------------------------
Regulatory assets -86.03%102K-97.12%15K-97.12%15K26.80%630K57.20%559K614.17%730K-39.84%521K-39.84%521K97.70%496.86K161.75%355.61K
Liabilities
Current liabilities
Current debt and capital lease obligation -5.29%179K-38.43%133K-38.43%133K-35.22%191K-59.74%133K-38.53%189K-26.53%216K-26.53%216K9.71%294.86K41.09%330.35K
-Current capital lease obligation -5.29%179K-38.43%133K-38.43%133K-35.22%191K-59.74%133K-38.53%189K-26.53%216K-26.53%216K9.71%294.86K41.09%330.35K
-accounts payable -----51.95%1.08M-51.95%1.08M--2.19M--629K----279.12%2.25M279.12%2.25M--------
-Total tax payable 8.02%7.68M1.93%7.02M1.93%7.02M2.27%7.05M2.22%7.08M1.44%7.11M-2.88%6.89M-2.88%6.89M-3.85%6.9M-4.40%6.92M
Current accrued expenses ----78.11%2.49M78.11%2.49M--2.35M--1.74M----0.29%1.4M0.29%1.4M--------
Current liabilities 66.18%4.1M7.40%4.24M7.40%4.24M173.26%10.02M4.20%2.65M1.85%2.47M46.65%3.95M46.65%3.95M35.33%3.67M-1.47%2.54M
Non current liabilities
-Long term debt 150.79%948K84.71%290K84.71%290K94.67%323K80.12%346K36.64%378K-56.51%157K-56.51%157K-62.46%165.92K-62.36%192.09K
Non current accrued expenses 62.86%1.37M-0.77%647K-0.77%647K-0.23%752K-10.56%744K-7.76%840K-33.20%652K-33.20%652K-24.64%753.71K-4.42%831.87K
Total non current liabilities 23.01%11.78M3.92%11.26M3.92%11.26M61.62%17.07M2.75%9.73M1.55%9.58M10.75%10.83M10.75%10.83M6.89%10.56M-3.63%9.47M
Shareholders'equity
Share capital 5.64%432.51M6.65%430.91M6.65%430.91M7.73%428.83M4.19%413.42M3.26%409.41M3.24%404.04M3.24%404.04M1.76%398.07M1.45%396.81M
-common stock 5.64%432.51M6.65%430.91M6.65%430.91M7.73%428.83M4.19%413.42M3.26%409.41M3.24%404.04M3.24%404.04M1.76%398.07M1.45%396.81M
Additional paid-in capital 5.75%42.69M5.16%42.12M5.16%42.12M5.82%41.59M4.09%40.39M16.18%40.37M17.24%40.05M17.24%40.05M18.43%39.3M20.41%38.8M
Gains losses not affecting retained earnings 1.67%670K-17.82%544K-17.82%544K-9.36%655K22.23%554K93.41%659K70.62%662K70.62%662K77.79%722.63K45.48%453.24K
Total equity -1.64%34.75M3.98%38.82M3.98%38.82M18.30%46.09M-20.56%31.97M-20.52%35.33M-18.63%37.33M-18.63%37.33M-25.92%38.96M-28.54%40.24M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg